L-carnitine reduces cochlear damage induced by gamma irradiation in guinea pigs

Annals of Clinical and Laboratory Science

Volumn 36, Issue 3, 2006, Pages 312-318

  Altas, Enver ^a,b   Ertekin, Mustafa Vecdi ^a   Gundogdu, Cemal ^a   Demirci, Elif ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Cochlear damage; Gamma irradiation; L carnitine; Radioprotection

Indexed keywords

CARNITINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCHLEA INJURY; CONTROLLED STUDY; DRUG EFFECT; GAMMA IRRADIATION; GUINEA PIG; HAIR CELL; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; SKULL IRRADIATION; SPIRAL GANGLION; STRIA VASCULARIS; TISSUE DEGENERATION;

ANIMALS; CARNITINE; COCHLEA; CRANIAL IRRADIATION; GAMMA RAYS; GUINEA PIGS; MALE; RADIATION INJURIES, EXPERIMENTAL;

CAVIA;

EID: 33748277838     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Ondrey FG, Greig JR, Herscher L. Radiation dose to otologic structures during head and neck cancer radiation therapy. Laryngoscope 2000;110:217-221.
2. Huang E, Teh BS, Strother DR, Davis QG, Chiu JK, Lu HH, Carpenter LS, Mai WY, Chintagumpala MM, South M. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int Radiat Oncol Biol Phys 2002;52:599-605.
3. Ho WK, Wei WI, Kwong DL, Sham JS, Tai PT, Yuen AP, Au DK. Long term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: a prospective study. Head Neck Surgery 1999;21:547-553.
4. Chang SD, Poen J, Hancock SL, Martin DP, Adler JR. Acute hearing loss following fractionated stereotactic radiosurgery for acoustic neuroma. Report of two cases. J Neurosurg 1998;89:321-325.
5. Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R. Radiotherapy-induced ear toxicity. Cancer Treat Rev 2003;29:417-430.
6. Mencher GT, Novotny G, Mencher L, Gulliver M. Ototoxicity and irradiation: additional etiologies of hearing loss in adults. J Am Acad Audiol 1995;6:351-357.
7. Schacht J. Biochemical basis of aminoglycoside ototoxicity. Otolaryngol Clin North Am 1993;26:845-856.
8. Li G, Frenz DA, Brahmblatt S, Feghali JG, Ruben RJ, Bergren D, Arezzo J, Van de Water TR. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy. Neurotoxicology 2001;22: 163-176.
9. Conlon BJ, Aran JM, Erre JP, Smith FW. Attenuation of aminoglycoside-induced cochlear damage with the metabolic antioxidant alpha lipoic acid. Hearing Res 1999;128:40-44.
10. Teranishi M, Nakashima T, Wakabayashi T. Effects of alpha-tocopherol on cisplatin-induced ototoxicity in guinea pigs. Hearing Res 2001;151:61-70.
11. Guneri EA, Serbetcioglu B, Ikiz AO, Guneri A, Ceryan K. TEOAE monitoring of cisplatin induced ototoxicity in guinea pigs: the protective effect of vitamin B treatment. Auris Nasus Larynx 2001;28:9-14.
12. Ciges M, Fernandez-Cervilla F, Crespo PV, Campos A. Pantothenic acid and coenzyme A in experimental cisplatin-induced ototoxia. Acta Otolaryngol 1996;116: 263-268.
13. Moyersoons F, Giurgea CE. Protective effect of piracetam in experimental barbiturate intoxication: EEG and behavioral studies. Arch Int Pharmacodyn 1974;210:38-48.
14. Kocer I, Kulacoglu D, Altuntas I, Gundogdu C, Gullulu G. Protection of the retina from ischemia-reperfusion injury by L-carnitine in guinea pigs. Eur J Ophthalmol 2003;13:80-85.
15. Altas E, Ucuncu H, Aktan B, Selimoglu E. The effect of piracetam in preventing combined cisplatin and gentamicin-induced ototoxicity in a guinea pig model. Pain Clinic 2004;16:427-435.
16. Iraz M, Kalcioglu MT, Kizilay A, Karatas E. Amino-guanidine prevents ototoxicity induced by cisplatin in rats. Ann Clin Lab Sci 2005;35:329-335.
17. Swamy-Mruthinti S, Carter AL. Acetyl-L-carnitine decreases glycation of lens proteins: in vitro studies. Exp Eye Res 1999;69:109-115.
18. Bertelli A, Conte A, Ronca G. L-propionyl carnitine protects erythrocytes and low density lipoproteins against peroxidation. Drugs Exp Clin Res 1994;20:191-197.
19. Di Giacomo C, Latteri F, Fichera C, Sorrenti V, Campisi A, Castorina C, Russo A, Pinturo R, Vanella A. Effect of acetyl-L-carnitine on lipid peroxidation and xanthine oxidase activity in rat skeletal muscle. Neurochem Res 1993;18:1157-1162.
20. Ferrari R, Ciampalini G, Agnoletti G, Cargnoni A, Ceconi C, Visioli O. Effect of L-carnitine derivatives on heart mitochondrial damage induced by lipid peroxidation. Pharmacol Res Commun 1988;20:125-132.
21. Koudelova J, Mourek J, Drahota Z, Rauchova H. Protective effect of carnitine on lipoperoxide formation in rat brain. Physiol Res 1994;43:387-389.
22. Izgut-Uysal VN, Agac A, Derin N. Effect of carnitine on stress-induced lipid peroxidation in rat gastric mucosa. J Gastroenterol 2001;36:231-236.
23. Fritz IB, Arrigoni-Martelli E. Sites of action of carnitine and its derivatives on the cardiovascular system: interactions with membranes. Trends Pharmacol Sci 1993;14: 355-360.
24. Kalkandelen S, Selimoglu E, Erdogan F, Ucuncu H, Altas E. Comparative cochlear toxicities of streptomycin, gentamycin, amikacin and netilmicin in guinea pigs. J Int Med Res 2002;30:406-412.
25. Ertekin MV, Uslu H, Karslioglu I, Ozbek E, Ozbek A. Effect of oral zinc sulphate supplementation on agents of oropharyngeal infection in patients receiving radiotherapy for head and neck cancer. J Int Med Res 2003; 31:251-266.
26. Ertekin MV, Koc M, Karslioglu I, Sezen O, Taysi S, Bakan N. The effects of oral zinc sulphate during radiotherapy on anti-oxidant enzyme activities in patients with head and neck cancer: a prospective, randomized, placebo-controlled study. Int J Clin Pract 2004;58:662-668.
27. Sha SH, Zajic G, Epstein CJ, Schacht J. Overexpression of copper/zinc-superoxide dismutase protects from kanamycin-induced hearing loss. Audiol Neurootol 2001;6:117-123.
28. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156:341-357.
29. Kim CS, Shin SO. Ultrastructural changes in the cochlea of the guinea pig after fast neutron irradiation. Otolaryngol Head Neck Surg 1994;110:419-427.
30. Yang X, Lu Y, Chen Z. Delayed damage of ionizing radiation on the inner ear (abstract). Zhonghua Er Bi Yan Hou Ke Za Zhi 1997;32:222-225.
31. Abd-Allah AR, Al-Majed AA, Al-Yahya AA, Fouda SI, Al-Shabana OA. L-Carnitine halts apoptosis and myelo-suppression induced by carboplatin in rat bone marrow cell cultures. Arch Toxicol 2005;79:406-413.
32. Ergun O, Ulman C, Kilicalp AS, Ulman I. Carnitine as a preventive agent in experimental renal ischemia-reperfusion injury. Urol Res 2001;29:186-189.
33. Tetik O, Yagdi T, Islamoglu F, Calkavur T, Posacioglu H, Atay Y, Ayik F, Canpolat L, Yuksel M. The effects of L-carnitine on spinal cord ischemia/reperfusion injury in rabbits. Thorac Cardiovasc Surg 2002;50:11-15.
34. Loster H, Bohm U. L-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions. Mol Cell Biochem 2001;217:83-90.
35. Luo X, Reichetzer B, Trines J, Benson LN, Lehotay DC. L-carnitine attenuates doxorubicin-induced lipid peroxidation in rats. Free Radic Biol Med 1999;26:1158-1165.
36. Kawasaki N, Lee JD, Shimizu H, Ueda T. Long-term 1-carnitine treatment prolongs the survival in rats with adriamycin-induced heart failure. J Card Fail 1996;2: 293-299.
37. Chang B, Nishikawa M, Sato E, Utsumi K, Inoue M. L-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch Biochem Biophys 2002;405:55-64.
38. Moretti S, Famularo G, Marcellini S, Boschini A, Santini G, Trinchieri V, Lucci L, Alesse E, De Simone C. L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine. Antioxid Redox Signal 2002;4:391-403.
39. Cifone MG, Alesse E, Di Marzio L, Ruggeri B, Zazzeroni F, Moretti S, Famularo G, Steinberg SM, Vullo E, De Simone C. Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation in peripheral blood lymphocytes from AIDS patients. Proc Assoc Am Phys 1997;109:146-153.
40. Arafa HM, Abd-Allah AR, El-Mahdy MA, Ramadan LA, Hamada FM. Immunomodulatory effects of L-carnitine and q10 in mouse spleen exposed to low-frequency high-intensity magnetic field. Toxicology 2003;187:171-181.
41. Rosenthal RE, Williams R, Bogaert YE, Getson PR, Fiskum G. Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine. Stroke 1992;23:1312-1318.
42. Vanella A, Russo A, Acquaviva R, Campisi A, Di Giacomo C, Sorrenti V, Barcellona ML. L-propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol 2000;16:99-104.
43. Rani PJ, Panneerselvam C. Effect of L-carnitine on brain lipid peroxidation and antioxidant enzymes in old rats. J Gerontol Biol Sci Med Sci 2002;57:134-137.
44. Reznick AZ, Kagan VE, Ramsey R, Tsuchiya M, Khwaja S, Serbinova EA, Packer L. Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation. Arch Biochem Biophys 1992;296:394-401.
45. Arockia Rani PJ, Panneerselvam C. Carnitine as a free radical scavenger in ageing. Exp Gerentol 2001;36:1713-1726.
46. Esposti D, Mariani M, Demartini G, Lucini V, Fraschini F, Mancia M. Modulation of melatonin secretion by acetyl-L-carnitine in adult and old rats. J Pineal Res 1994;17:132-136.
47. Olatunji-Bello II, Reiter RJ. Effect of acute acetyl-l-carnitine treatment on daytime melatonin synthesis in the rat. Afr J Med Med Sci 1997;26:175-177.